Catalyst Wire Dossier Catalyst Wire Dossier

Lipotecan

TLC388 HCl · Taiwan Liposome Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lipotecan, covering 2012-02-09 to 2012-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors [Phase 1]

See pricing